Marshall Wace
CELG

Marshall Wace’s Celgene Corp CELG Stock Holding History

Marshall Wace’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-580,249
Closed -$57.6M – 2311
2019
Q3 		$57.6M Buy
580,249
+211,803
+57% +$20.1M 0.45% 41
2019
Q2 		$34.1M Buy
368,446
+165,055
+81% +$15.7M 0.28% 71
2019
Q1 		$19.2M Buy
203,391
+178,036
+702% +$15.6M 0.18% 136
2018
Q4 		$1.63M Sell
25,355
-257,717
-91% -$19M 0.02% 780
2018
Q3 		$25.3M Buy
283,072
+261,811
+1,231% +$23.1M 0.22% 125
2018
Q2 		$1.69M Buy
21,261
+16,001
+304% +$1.33M 0.03% 446
2018
Q1 		$469K Buy
+5,260
New +$505K 0.02% 378
2017
Q4 		– Sell
-11,725
Closed -$1.71M – 534
2017
Q3 		$1.71M Buy
+11,725
New +$1.6M 0.08% 178
2017
Q2 		– Sell
-2,202
Closed -$273K – 442
2017
Q1 		$273K Sell
2,202
-467,309
-100% -$55.9M 0.01% 274
2016
Q4 		$54.3M Buy
469,511
+390,266
+492% +$43.5M 0.36% 67
2016
Q3 		$8.28M Buy
79,245
+8,875
+13% +$961K 0.06% 314
2016
Q2 		$6.94M Buy
70,370
+9,559
+16% +$989K 0.06% 331
2016
Q1 		$6.09M Buy
60,811
+55,705
+1,091% +$5.74M 0.06% 302
2015
Q4 		$611K Buy
+5,106
New +$591K 0.01% 776
2015
Q3 		– Sell
-155,461
Closed -$18M – 1233
2015
Q2 		$18M Buy
155,461
+113,933
+274% +$13M 0.23% 111
2015
Q1 		$4.79M Sell
41,528
-95,201
-70% -$11.4M 0.06% 325
2014
Q4 		$15.3M Sell
136,729
-302,870
-69% -$31.9M 0.2% 137
2014
Q3 		$41.7M Buy
439,599
+6,478
+1% +$585K 0.6% 37
2014
Q2 		$37.2M Buy
433,121
+142,209
+49% +$10.8M 0.55% 38
2014
Q1 		$20.3M Buy
+290,912
New +$23M 0.37% 79

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Marshall Wace's CELG Position: Q4 2019 in Review

Marshall Wace sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 580,249 shares — an estimated $57.6M sold.

Marshall Wace first reported a position in CELG in Q1 2014 and held it in 20 quarters. The position peaked at $57.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Marshall Wace reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace sold 580,249 Celgene Corp shares in Q4 2019, an estimated $57.6M.
  • Marshall Wace first reported a position in Celgene Corp in Q1 2014 and held it in 20 quarters.
  • Marshall Wace's Celgene Corp position peaked at $57.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.